Amifostine trihydrate T6381
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Amifostine is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin.
CAS nr:
112901-68-5
Purity:
98%
Molecular Weight:
268,27
SMILES:
O.O.O.NCCCNCCSP(O)(O)=O
Formula:
C5H15N2O3PS�3H2O
Pathway:
Others,Metabolism,Chromatin/Epigenetic
Target:
Others,HIF/HIF Prolyl-Hydroxylase,HIF/HIF Prolyl-Hydroxylase
